Examining Bioactivity of PVSRIPO in Invasive Breast Cancer

Clinical trial NCT03564782 · COMPLETED

Trial details

NCT number: NCT03564782
Sponsor: Istari Oncology, Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Invasive Breast Cancer

Start date: 2019-06-30
Primary completion: 2022-04-11
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.